Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Charles T. Quinn, MD, MS
Healthcare Provider Medical Director
Cincinnati Children's Hospital
Erythrocyte Diagnostic Laboratory
3333 Burnet Avenue
Cincinnati, Ohio, United States
Dr. Quinn is Associate Professor of clinical pediatrics at the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center. He has a long-standing interest in sickle cell anemia and thalassemia. He serves on the ASH Committee on Educational Affairs and on the Publications Committee. Dr. Quinn is one of the resident pediatric hematologists at Cincinnati Children’s Hospital Medical Center.
Clinical Interests:
Sickle cell disease; thalassemia; hemoglobinopathies; anemia; autoimmune hemolytic anemia; disorders of red blood cells; iron overload and iron chelation; chronic transfusion therapy; immune thrombocytopenia (ITP); neutropenia; stroke.
Research Interests:
Epidemiology, pathophysiology, treatment and prevention of brain injury (structural and cognitive) in sickle cell disease; measurement of red blood cell turnover in sickle cell disease; identification and treatment of cardiomyopathy and nephropathy in sickle cell disease; treatment and prevention of pain (VOC) in sickle cell disease; MRI methods of iron quantitation; new agents for immune thrombocytopenia (ITP)
Representative Publications:
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial
Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia
Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease
Acute silent cerebral infarction in children with sickle cell anemia
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia
Related Content
-
Coretta Jenerette, PhD, RNCoretta M. Jenerette, PhD, RN, CNE, earn...
-
Implementation of a social worker screening process to explore unmet psychological and social needs for adults with ...The most common symptom for persons with...
-
Michael Rutledge Debaun, MDMichael R. DeBaun is the professor of Pe...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
-
Sickle Cell Patients Endure Discrimination, Poor Care And Shortened LivesFor more than a year, NeDina Brocks-Capl...
-
Sickle Cell Disease Coalition (SCDC)https://www.youtube.com/watch?v=oQP-Uq0B...
-
Newark Beth Israel Medical CenterNewark Beth Israel Medical Center treats...